Annual Working Capital
$2.11 B
+$94.10 M+4.67%
December 31, 2024
Summary
- As of February 20, 2025, ALNY annual working capital is $2.11 billion, with the most recent change of +$94.10 million (+4.67%) on December 31, 2024.
- During the last 3 years, ALNY annual working capital has fallen by -$3.85 million (-0.18%).
- ALNY annual working capital is now -0.18% below its all-time high of $2.11 billion, reached on December 31, 2021.
Performance
ALNY Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$2.11 B
-$25.75 M-1.21%
December 31, 2024
Summary
- As of February 20, 2025, ALNY quarterly working capital is $2.11 billion, with the most recent change of -$25.75 million (-1.21%) on December 31, 2024.
- Over the past year, ALNY quarterly working capital has increased by +$94.10 million (+4.67%).
- ALNY quarterly working capital is now -2.83% below its all-time high of $2.17 billion, reached on June 30, 2021.
Performance
ALNY Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ALNY Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +4.7% | +4.7% |
3 y3 years | -0.2% | +4.7% |
5 y5 years | +54.7% | +4.7% |
ALNY Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -0.2% | +9.6% | -1.2% | +21.5% |
5 y | 5-year | -0.2% | +54.7% | -2.8% | +69.3% |
alltime | all time | -0.2% | >+9999.0% | -2.8% | >+9999.0% |
Alnylam Pharmaceuticals Working Capital History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $2.11 B(+4.7%) | $2.11 B(-1.2%) |
Sep 2024 | - | $2.13 B(+0.8%) |
Jun 2024 | - | $2.12 B(+3.5%) |
Mar 2024 | - | $2.05 B(+1.6%) |
Dec 2023 | $2.01 B(+4.7%) | $2.01 B(-1.0%) |
Sep 2023 | - | $2.04 B(+17.3%) |
Jun 2023 | - | $1.74 B(-7.1%) |
Mar 2023 | - | $1.87 B(-2.9%) |
Dec 2022 | $1.92 B(-8.9%) | $1.92 B(+0.3%) |
Sep 2022 | - | $1.92 B(+5.7%) |
Jun 2022 | - | $1.81 B(-8.6%) |
Mar 2022 | - | $1.98 B(-6.1%) |
Dec 2021 | $2.11 B(+4.1%) | $2.11 B(+2.3%) |
Sep 2021 | - | $2.06 B(-4.9%) |
Jun 2021 | - | $2.17 B(+47.1%) |
Mar 2021 | - | $1.48 B(-27.3%) |
Dec 2020 | $2.03 B(+48.9%) | $2.03 B(+28.9%) |
Sep 2020 | - | $1.57 B(-11.4%) |
Jun 2020 | - | $1.78 B(+42.5%) |
Mar 2020 | - | $1.25 B(-8.6%) |
Dec 2019 | $1.36 B(+33.5%) | $1.36 B(-11.7%) |
Sep 2019 | - | $1.54 B(-11.0%) |
Jun 2019 | - | $1.74 B(+39.6%) |
Mar 2019 | - | $1.24 B(+21.7%) |
Dec 2018 | $1.02 B(-37.0%) | $1.02 B(-16.3%) |
Sep 2018 | - | $1.22 B(-12.1%) |
Jun 2018 | - | $1.39 B(-11.5%) |
Mar 2018 | - | $1.57 B(-3.1%) |
Dec 2017 | $1.62 B(+200.0%) | $1.62 B(+81.6%) |
Sep 2017 | - | $892.32 M(+4.7%) |
Jun 2017 | - | $851.98 M(+69.9%) |
Mar 2017 | - | $501.40 M(-7.2%) |
Dec 2016 | $540.18 M(-48.2%) | $540.18 M(-18.9%) |
Sep 2016 | - | $665.80 M(-18.6%) |
Jun 2016 | - | $817.49 M(-16.9%) |
Mar 2016 | - | $983.71 M(-5.7%) |
Dec 2015 | $1.04 B(+60.3%) | $1.04 B(+6.0%) |
Sep 2015 | - | $984.68 M(+2.3%) |
Jun 2015 | - | $962.55 M(-4.6%) |
Mar 2015 | - | $1.01 B(+55.1%) |
Dec 2014 | $651.03 M | $651.03 M(+11.1%) |
Sep 2014 | - | $586.17 M(-4.1%) |
Jun 2014 | - | $611.38 M(+3.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2014 | - | $590.23 M(+194.9%) |
Dec 2013 | $200.16 M(+159.2%) | $200.16 M(+38.7%) |
Sep 2013 | - | $144.27 M(-10.6%) |
Jun 2013 | - | $161.29 M(-15.3%) |
Mar 2013 | - | $190.36 M(+146.5%) |
Dec 2012 | $77.21 M(+8.7%) | $77.21 M(-57.4%) |
Sep 2012 | - | $181.18 M(-1.1%) |
Jun 2012 | - | $183.28 M(+29.2%) |
Mar 2012 | - | $141.90 M(+99.8%) |
Dec 2011 | $71.04 M(-53.3%) | $71.04 M(-17.4%) |
Sep 2011 | - | $86.03 M(-30.5%) |
Jun 2011 | - | $123.80 M(-18.2%) |
Mar 2011 | - | $151.37 M(-0.5%) |
Dec 2010 | $152.09 M(-16.8%) | $152.09 M(+4.8%) |
Sep 2010 | - | $145.19 M(-15.3%) |
Jun 2010 | - | $171.48 M(-1.9%) |
Mar 2010 | - | $174.74 M(-4.4%) |
Dec 2009 | $182.80 M(-46.8%) | $182.80 M(+43.9%) |
Sep 2009 | - | $127.04 M(-27.9%) |
Jun 2009 | - | $176.09 M(-44.1%) |
Mar 2009 | - | $315.09 M(-8.3%) |
Dec 2008 | $343.67 M(+9.3%) | $343.67 M(-1.7%) |
Sep 2008 | - | $349.75 M(-21.4%) |
Jun 2008 | - | $444.90 M(+20.1%) |
Mar 2008 | - | $370.56 M(+17.9%) |
Dec 2007 | $314.43 M(+57.3%) | $314.43 M(-19.4%) |
Sep 2007 | - | $390.18 M(+123.1%) |
Jun 2007 | - | $174.85 M(-6.2%) |
Mar 2007 | - | $186.42 M(-6.7%) |
Dec 2006 | $199.86 M(+212.6%) | $199.86 M(+89.8%) |
Sep 2006 | - | $105.30 M(-2.9%) |
Jun 2006 | - | $108.46 M(-7.4%) |
Mar 2006 | - | $117.13 M(+83.2%) |
Dec 2005 | $63.93 M(+53.7%) | $63.93 M(+242.0%) |
Sep 2005 | - | $18.70 M(-24.7%) |
Jun 2005 | - | $24.82 M(-29.7%) |
Mar 2005 | - | $35.30 M(-15.1%) |
Dec 2004 | $41.61 M(+104.5%) | $41.61 M(+2.6%) |
Sep 2004 | - | $40.56 M(-3.0%) |
Jun 2004 | - | $41.81 M(+190.5%) |
Mar 2004 | - | $14.39 M(-29.3%) |
Dec 2003 | $20.34 M(+58.4%) | $20.34 M |
Dec 2002 | $12.85 M | - |
FAQ
- What is Alnylam Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual working capital year-on-year change?
- What is Alnylam Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly working capital year-on-year change?
What is Alnylam Pharmaceuticals annual working capital?
The current annual working capital of ALNY is $2.11 B
What is the all time high annual working capital for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual working capital is $2.11 B
What is Alnylam Pharmaceuticals annual working capital year-on-year change?
Over the past year, ALNY annual working capital has changed by +$94.10 M (+4.67%)
What is Alnylam Pharmaceuticals quarterly working capital?
The current quarterly working capital of ALNY is $2.11 B
What is the all time high quarterly working capital for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly working capital is $2.17 B
What is Alnylam Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, ALNY quarterly working capital has changed by +$94.10 M (+4.67%)